The days of using cadavers or animals for
medical training and surgical preparation may be numbered
3D printing leader Stratasys Ltd. (NASDAQ: SSYS) is further
extending its commitment to the medical industry with the new J750™
Digital Anatomy™ 3D Printer. Designed to replicate the feel,
responsiveness, and biomechanics of human anatomy in medical models
– the system improves surgical preparedness and training while
helping bring new medical devices to market faster.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20191007005113/en/
3D printed heart model produced on the
new Stratasys J750™ Digital Anatomy™ 3D Printer - replicating the
feel, responsiveness, and biomechanics of human anatomy (Photo:
Business Wire)
Today, medical professionals have a choice of cadavers, animal,
traditional, or virtual reality models which all have significant
limitations. Unlike animal models that only approximate human
anatomy and may raise ethical concerns, or cadaver models that
cannot retain live-tissue feel and require a controlled
environment, the Digital Anatomy 3D Printer recreates actual tissue
response - and can be used anywhere without specialized facilities.
It also lets users focus on specific pathologies.
“We believe in the potential of 3D printing to provide better
health care, and the Digital Anatomy 3D Printer is a major step
forward,” said Stratasys Healthcare Business Unit Head Eyal Miller.
“We’re giving surgeons a more realistic training environment in
no-risk settings. We also anticipate this will enable medical
device makers to improve how they bring products to market by
performing design verification, validation, usability studies and
failure analysis with these new models.”
The new 3D printer has already been tested at several
organizations. The Jacobs Institute, a Buffalo, N.Y.-based medical
innovation center focused on accelerating device development in
vascular medicine, has been testing the Digital Anatomy 3D Printer
to re-create key vascular components for advanced testing and
training. “3D printing has been wonderful for recreating
patient-specific anatomy compared to cadavers or animal models;
however, the final frontier for organ model realism has been
live-tissue feel and biomechanical realism,” said Dr. Adnan
Siddiqui, Chief Medical Officer, Jacobs Institute. “That’s exactly
what the Digital Anatomy 3D Printer gives us. We believe these
models give us the best opportunity to recreate human physiological
conditions to simulate actual clinical situations and to study new
devices to establish their effectiveness before introducing them to
patients.”
In conjunction with the 3D printer itself, Stratasys is also
introducing three new materials – TissueMatrix™, GelMatrix™, and
BoneMatrix™ - used to create cardiac, vascular, and orthopedic 3D
printing applications. A Blood Vessel Cleaning Station that removes
support material from inside 3D-printed blood vessels is also being
released.
The new Stratasys 3D printer is expected to see adoption
primarily by medical device companies, which require new ways to
drive faster adoption of technologies and procedures - and academic
medical centers, which are under increasing pressure to conduct
training outside of the operating room to minimize risk to
patients. The solution also supports efforts to move from
time-based surgical training to proficiency-based evaluation.
The J750 Digital Anatomy 3D Printer builds on Stratasys’s
investments and growing success in the healthcare market, both with
medical practitioners and device makers. Last November, its J750
and J735 3D Printers and the Objet30 Prime 3D Printer were
validated by partner Materialise for use with FDA-cleared
Materialise Mimics inPrint software for creating anatomical models
used in patient care. The company has worked closely with the
Veterans Health Administration on applying both FDM® and PolyJet
technologies to a variety of healthcare settings, including a jaw
reconstruction application that reduced surgical time by 80-100
minutes. Additionally, Bordeaux University Hospital in France
recently integrated the Stratasys J750 in their process to 3D print
life-like transparent and color models of patient kidneys for
complex tumor removal cases.
For more information on the new J750 Digital Anatomy 3D Printer
and how 3D printing is transforming healthcare, please see
https://www.stratasys.com/3d-printers/j735-j750.
Stratasys is a global leader in additive manufacturing or
3D printing technology and is the manufacturer of FDM® and PolyJet™
3D printers. The company’s technologies are used to create
prototypes, manufacturing tools, and production parts for
industries, including aerospace, automotive, healthcare, consumer
products and education. For 30 years, Stratasys products have
helped manufacturers reduce product-development time, cost, and
time-to-market, as well as reduce or eliminate tooling costs and
improve product quality. The Stratasys 3D printing ecosystem of
solutions and expertise includes 3D printers, materials, software,
expert services, and on-demand parts production. Online at:
www.stratasys.com, http://blog.stratasys.com and LinkedIn.
Stratasys, PolyJet, J750, Digital Anatomy 3D Printer,
TissueMatrix, GelMatrix, and BoneMatrix are trademarks of Stratasys
Ltd. and/or its affiliates. All other trademarks are the property
of their respective owners, and Stratasys assumes no responsibility
with regard to the selection, performance, or use of these
non-Stratasys products.
Attention Editors, if you publish reader-contact information,
please use:
- USA +800-801-6491
- Europe/Middle East/Africa +49-7229-7772-0
- Asia Pacific +852 3944-8888
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191007005113/en/
Stratasys Corporate & North America
Craig.Librett@Stratasys.com +1 612-364-3208
Europe, Middle East, and Africa Jonathan Wake / Miguel
Afonso, Incus Media stratasys@incus-media.com +44 1737 215200
Mexico, Caribe Carlos.ramirez@stratasys.com 00+52 (55)
15349791
Asia Pacific and Japan Alice Chiu
alice.chiu@stratasys.com
Brazil, Central America and South America
Erica.massini@stratasys.com +55 (11) 2626-9229
Stratasys (NASDAQ:SSYS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Stratasys (NASDAQ:SSYS)
Historical Stock Chart
From Sep 2023 to Sep 2024